ID   MYH14_HUMAN             Reviewed;        1995 AA.
AC   Q7Z406; B0I1S2; C3TTN4; Q5CZ75; Q6XYE4; Q76B62; Q8WV23; Q96I22;
AC   Q9BT27; Q9BW35; Q9H882;
DT   19-JUL-2005, integrated into UniProtKB/Swiss-Prot.
DT   05-APR-2011, sequence version 2.
DT   22-JUL-2015, entry version 119.
DE   RecName: Full=Myosin-14;
DE   AltName: Full=Myosin heavy chain 14;
DE   AltName: Full=Myosin heavy chain, non-muscle IIc;
DE   AltName: Full=Non-muscle myosin heavy chain IIc;
DE            Short=NMHC II-C;
GN   Name=MYH14; Synonyms=KIAA2034; ORFNames=FP17425;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), ALTERNATIVE SPLICING, AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Sciatic nerve;
RX   PubMed=12909352; DOI=10.1016/S0378-1119(03)00613-9;
RA   Leal A., Endele S., Stengel C., Huehne K., Loetterle J., Barrantes R.,
RA   Winterpacht A., Rautenstrauss B.;
RT   "A novel myosin heavy chain gene in human chromosome 19q13.3.";
RL   Gene 312:165-171(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RA   Nagase T., Kikuno R., Yamakawa H., Ohara O.;
RT   "The nucleotide sequence of a long cDNA clone isolated from human.";
RL   Submitted (JAN-2007) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [4]
RP   PROTEIN SEQUENCE OF 2-11; 190-204; 343-353; 403-413; 434-445; 607-613;
RP   669-675; 718-726; 839-845; 899-906; 957-963; 984-990; 1105-1115;
RP   1244-1264; 1469-1478; 1553-1562 AND 1686-1693, CLEAVAGE OF INITIATOR
RP   METHIONINE, ACETYLATION AT ALA-2, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Colon carcinoma;
RA   Bienvenut W.V., Heiserich L., Boulahbel H., Gottlieb E.;
RL   Submitted (NOV-2006) to UniProtKB.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 68-998 AND 1740-1995
RP   (ISOFORM 1), NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1297-1995
RP   (ISOFORM 4), NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1297-1995
RP   (ISOFORM 5), AND NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 209-477
RP   (ISOFORM 6).
RC   TISSUE=Colon, Lung, Muscle, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 590-773 (ISOFORM 2), AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=19240025; DOI=10.1074/jbc.M806574200;
RA   Jana S.S., Kim K.Y., Mao J., Kawamoto S., Sellers J.R.,
RA   Adelstein R.S.;
RT   "An alternatively spliced isoform of non-muscle myosin II-C is not
RT   regulated by myosin light chain phosphorylation.";
RL   J. Biol. Chem. 284:11563-11571(2009).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 964-1995 (ISOFORM 1).
RX   PubMed=15498874; DOI=10.1073/pnas.0404089101;
RA   Wan D., Gong Y., Qin W., Zhang P., Li J., Wei L., Zhou X., Li H.,
RA   Qiu X., Zhong F., He L., Yu J., Yao G., Jiang H., Qian L., Yu Y.,
RA   Shu H., Chen X., Xu H., Guo M., Pan Z., Chen Y., Ge C., Yang S.,
RA   Gu J.;
RT   "Large-scale cDNA transfection screening for genes related to cancer
RT   development and progression.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:15724-15729(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1335-1995 (ISOFORM 1).
RC   TISSUE=Lymph node;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1431-1995 (ISOFORM 1).
RC   TISSUE=Thyroid;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [10]
RP   IDENTIFICATION.
RX   PubMed=11919279; DOI=10.1093/oxfordjournals.molbev.a004093;
RA   Desjardins P.R., Burkman J.M., Shrager J.B., Allmond L.A.,
RA   Stedman H.H.;
RT   "Evolutionary implications of three novel members of the human
RT   sarcomeric myosin heavy chain gene family.";
RL   Mol. Biol. Evol. 19:375-393(2002).
RN   [11]
RP   TISSUE SPECIFICITY.
RX   PubMed=14594953; DOI=10.1074/jbc.M309981200;
RA   Golomb E., Ma X., Jana S.S., Preston Y.A., Kawamoto S., Shoham N.G.,
RA   Goldin E., Conti M.A., Sellers J.R., Adelstein R.S.;
RT   "Identification and characterization of nonmuscle myosin II-C, a new
RT   member of the myosin II family.";
RL   J. Biol. Chem. 279:2800-2808(2004).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1969 AND SER-1989, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-60; SER-1969; SER-1980;
RP   SER-1983 AND SER-1989, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [16]
RP   VARIANTS DFNA4A CYS-376; SER-726 AND PHE-976, AND VARIANTS VAL-266 AND
RP   SER-1559.
RX   PubMed=15015131; DOI=10.1086/383285;
RA   Donaudy F., Snoeckx R., Pfister M., Zenner H.-P., Blin N.,
RA   Di Stazio M., Ferrara A., Lanzara C., Ficarella R., Declau F.,
RA   Pusch C.M., Nuernberg P., Melchionda S., Zelante L., Ballana E.,
RA   Estivill X., Van Camp G., Gasparini P., Savoia A.;
RT   "Nonmuscle myosin heavy-chain gene MYH14 is expressed in cochlea and
RT   mutated in patients affected by autosomal dominant hearing impairment
RT   (DFNA4).";
RL   Am. J. Hum. Genet. 74:770-776(2004).
RN   [17]
RP   VARIANT DFNA4A LEU-120.
RX   PubMed=16222661; DOI=10.1002/ajmg.a.30989;
RA   Yang T., Pfister M., Blin N., Zenner H.P., Pusch C.M., Smith R.J.H.;
RT   "Genetic heterogeneity of deafness phenotypes linked to DFNA4.";
RL   Am. J. Med. Genet. A 139:9-12(2005).
RN   [18]
RP   VARIANT PNMHH LEU-933, AND VARIANT VAL-1154.
RX   PubMed=21480433; DOI=10.1002/humu.21488;
RA   Choi B.O., Kang S.H., Hyun Y.S., Kanwal S., Park S.W., Koo H.,
RA   Kim S.B., Choi Y.C., Yoo J.H., Kim J.W., Park K.D., Choi K.G.,
RA   Kim S.J., Zuchner S., Chung K.W.;
RT   "A complex phenotype of peripheral neuropathy, myopathy, hoarseness,
RT   and hearing loss is linked to an autosomal dominant mutation in
RT   MYH14.";
RL   Hum. Mutat. 32:669-677(2011).
CC   -!- FUNCTION: Cellular myosin that appears to play a role in
CC       cytokinesis, cell shape, and specialized functions such as
CC       secretion and capping. {ECO:0000250}.
CC   -!- SUBUNIT: Myosin is a hexameric protein that consists of 2 heavy
CC       chain subunits (MHC), 2 alkali light chain subunits (MLC) and 2
CC       regulatory light chain subunits (MLC-2). {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=Q7Z406-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q7Z406-2; Sequence=VSP_040881, VSP_040882;
CC       Name=4;
CC         IsoId=Q7Z406-4; Sequence=VSP_014628;
CC       Name=5;
CC         IsoId=Q7Z406-5; Sequence=VSP_014629, VSP_014630;
CC       Name=6;
CC         IsoId=Q7Z406-6; Sequence=VSP_040881;
CC   -!- TISSUE SPECIFICITY: High levels of expression are found in brain
CC       (highest in corpus callosum), heart, kidney, liver, lung, small
CC       intestine, colon and skeletal muscle. Expression is low in organs
CC       composed mainly of smooth muscle, such as aorta, uterus and
CC       urinary bladder. No detectable expression is found in thymus,
CC       spleen, placenta and lymphocytes. {ECO:0000269|PubMed:12909352,
CC       ECO:0000269|PubMed:14594953, ECO:0000269|PubMed:19240025}.
CC   -!- DOMAIN: The rodlike tail sequence is highly repetitive, showing
CC       cycles of a 28-residue repeat pattern composed of 4 heptapeptides,
CC       characteristic for alpha-helical coiled coils. {ECO:0000250}.
CC   -!- DISEASE: Deafness, autosomal dominant, 4A (DFNA4A) [MIM:600652]: A
CC       form of non-syndromic sensorineural hearing loss. Sensorineural
CC       deafness results from damage to the neural receptors of the inner
CC       ear, the nerve pathways to the brain, or the area of the brain
CC       that receives sound information. {ECO:0000269|PubMed:15015131,
CC       ECO:0000269|PubMed:16222661}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Peripheral neuropathy, myopathy, hoarseness, and hearing
CC       loss (PNMHH) [MIM:614369]: A complex phenotype of progressive
CC       peripheral neuropathy and distal myopathy, with later onset of
CC       hoarseness and hearing loss. Affected individuals develop distal
CC       muscle weakness at a mean age of 10.6 years, followed by
CC       progressive atrophy of these muscles. The lower limbs are more
CC       severely affected than the upper limbs, and the muscle weakness
CC       first affects anterior leg muscles and later posterior leg
CC       muscles. {ECO:0000269|PubMed:21480433}. Note=The disease is caused
CC       by mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the TRAFAC class myosin-kinesin ATPase
CC       superfamily. Myosin family. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 IQ domain. {ECO:0000255|PROSITE-
CC       ProRule:PRU00116}.
CC   -!- SIMILARITY: Contains 1 myosin motor domain. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAO39147.1; Type=Frameshift; Positions=1017, 1057; Evidence={ECO:0000305};
CC       Sequence=AAP34449.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAP34449.1; Type=Frameshift; Positions=1016, 1057, 1490, 1755; Evidence={ECO:0000305};
CC       Sequence=BAB14735.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BG468611; Type=Erroneous termination; Positions=403; Note=Translated as Leu.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY165122; AAO39147.1; ALT_FRAME; mRNA.
DR   EMBL; AB111886; BAC98374.1; -; mRNA.
DR   EMBL; AB290169; BAG06723.1; -; mRNA.
DR   EMBL; AC008655; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC010515; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC020906; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC000676; AAH00676.2; -; mRNA.
DR   EMBL; BC004396; AAH04396.1; -; mRNA.
DR   EMBL; BC007877; AAH07877.2; -; mRNA.
DR   EMBL; BC018933; AAH18933.2; -; mRNA.
DR   EMBL; FJ041910; ACM78630.1; -; mRNA.
DR   EMBL; BG468611; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AY203926; AAP34449.1; ALT_SEQ; mRNA.
DR   EMBL; CR936653; CAI56791.1; -; mRNA.
DR   EMBL; AK023943; BAB14735.1; ALT_INIT; mRNA.
DR   CCDS; CCDS46151.1; -. [Q7Z406-6]
DR   CCDS; CCDS54295.1; -. [Q7Z406-2]
DR   CCDS; CCDS59411.1; -. [Q7Z406-1]
DR   RefSeq; NP_001070654.1; NM_001077186.1. [Q7Z406-6]
DR   RefSeq; NP_001139281.1; NM_001145809.1. [Q7Z406-2]
DR   RefSeq; NP_079005.3; NM_024729.3. [Q7Z406-1]
DR   RefSeq; XP_006723449.1; XM_006723386.2. [Q7Z406-6]
DR   RefSeq; XP_011525625.1; XM_011527323.1. [Q7Z406-6]
DR   UniGene; Hs.467142; -.
DR   PDB; 2YCU; X-ray; 2.25 A; A=47-799.
DR   PDBsum; 2YCU; -.
DR   ProteinModelPortal; Q7Z406; -.
DR   SMR; Q7Z406; 47-921.
DR   BioGrid; 122884; 27.
DR   DIP; DIP-33170N; -.
DR   IntAct; Q7Z406; 13.
DR   MINT; MINT-1146777; -.
DR   STRING; 9606.ENSP00000262269; -.
DR   PhosphoSite; Q7Z406; -.
DR   BioMuta; MYH14; -.
DR   DMDM; 327478526; -.
DR   MaxQB; Q7Z406; -.
DR   PaxDb; Q7Z406; -.
DR   PRIDE; Q7Z406; -.
DR   Ensembl; ENST00000376970; ENSP00000366169; ENSG00000105357.
DR   Ensembl; ENST00000425460; ENSP00000407879; ENSG00000105357. [Q7Z406-6]
DR   Ensembl; ENST00000596571; ENSP00000472819; ENSG00000105357.
DR   Ensembl; ENST00000598205; ENSP00000472543; ENSG00000105357. [Q7Z406-6]
DR   Ensembl; ENST00000601313; ENSP00000470298; ENSG00000105357. [Q7Z406-2]
DR   GeneID; 79784; -.
DR   KEGG; hsa:79784; -.
DR   UCSC; uc002prq.1; human. [Q7Z406-6]
DR   UCSC; uc002prr.1; human. [Q7Z406-1]
DR   UCSC; uc010enu.1; human. [Q7Z406-2]
DR   CTD; 79784; -.
DR   GeneCards; GC19P050706; -.
DR   GeneReviews; MYH14; -.
DR   H-InvDB; HIX0015356; -.
DR   HGNC; HGNC:23212; MYH14.
DR   MIM; 600652; phenotype.
DR   MIM; 608568; gene.
DR   MIM; 614369; phenotype.
DR   neXtProt; NX_Q7Z406; -.
DR   Orphanet; 90635; Autosomal dominant non-syndromic sensorineural deafness type DFNA.
DR   Orphanet; 397744; Peripheral neuropathy-myopathy-hoarseness-hearing loss syndrome.
DR   PharmGKB; PA134935217; -.
DR   eggNOG; COG5022; -.
DR   GeneTree; ENSGT00760000118919; -.
DR   HOVERGEN; HBG004704; -.
DR   InParanoid; Q7Z406; -.
DR   KO; K10352; -.
DR   OMA; GARARHK; -.
DR   OrthoDB; EOG71CFK3; -.
DR   PhylomeDB; Q7Z406; -.
DR   TreeFam; TF333601; -.
DR   Reactome; REACT_19277; Sema4D induced cell migration and growth-cone collapse.
DR   Reactome; REACT_264548; EPHA-mediated growth cone collapse.
DR   Reactome; REACT_355192; RHO GTPases Activate ROCKs.
DR   Reactome; REACT_355303; RHO GTPases activate CIT.
DR   Reactome; REACT_355347; RHO GTPases activate PAKs.
DR   Reactome; REACT_355542; RHO GTPases activate PKNs.
DR   ChiTaRS; MYH14; human.
DR   GeneWiki; MYH14; -.
DR   GenomeRNAi; 79784; -.
DR   NextBio; 35482592; -.
DR   PRO; PR:Q7Z406; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; Q7Z406; -.
DR   ExpressionAtlas; Q7Z406; baseline and differential.
DR   Genevisible; Q7Z406; HS.
DR   GO; GO:0042641; C:actomyosin; IDA:UniProtKB.
DR   GO; GO:0030424; C:axon; IEA:Ensembl.
DR   GO; GO:0005903; C:brush border; IEA:Ensembl.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0030426; C:growth cone; IEA:Ensembl.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0043209; C:myelin sheath; IEA:Ensembl.
DR   GO; GO:0016460; C:myosin II complex; IDA:UniProtKB.
DR   GO; GO:0097513; C:myosin II filament; IDA:UniProtKB.
DR   GO; GO:0001725; C:stress fiber; IEA:Ensembl.
DR   GO; GO:0030898; F:actin-dependent ATPase activity; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0000146; F:microfilament motor activity; IEA:Ensembl.
DR   GO; GO:0030048; P:actin filament-based movement; IEA:Ensembl.
DR   GO; GO:0031032; P:actomyosin structure organization; IDA:UniProtKB.
DR   GO; GO:0007411; P:axon guidance; TAS:Reactome.
DR   GO; GO:0048013; P:ephrin receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0008152; P:metabolic process; IDA:GOC.
DR   GO; GO:0070584; P:mitochondrion morphogenesis; IMP:UniProtKB.
DR   GO; GO:0019228; P:neuronal action potential; IMP:UniProtKB.
DR   GO; GO:0008360; P:regulation of cell shape; IEA:UniProtKB-KW.
DR   GO; GO:0007605; P:sensory perception of sound; IMP:UniProtKB.
DR   GO; GO:0003009; P:skeletal muscle contraction; IMP:UniProtKB.
DR   GO; GO:0007519; P:skeletal muscle tissue development; IMP:UniProtKB.
DR   GO; GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome.
DR   GO; GO:0071625; P:vocalization behavior; IMP:UniProtKB.
DR   Gene3D; 4.10.270.10; -; 1.
DR   InterPro; IPR000048; IQ_motif_EF-hand-BS.
DR   InterPro; IPR027401; Myosin-like_IQ_dom.
DR   InterPro; IPR001609; Myosin_head_motor_dom.
DR   InterPro; IPR002928; Myosin_tail.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   Pfam; PF00063; Myosin_head; 1.
DR   Pfam; PF01576; Myosin_tail_1; 1.
DR   PRINTS; PR00193; MYOSINHEAVY.
DR   SMART; SM00015; IQ; 1.
DR   SMART; SM00242; MYSc; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS50096; IQ; 1.
DR   PROSITE; PS51456; MYOSIN_MOTOR; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Actin-binding; Alternative splicing;
KW   ATP-binding; Calmodulin-binding; Cell shape; Coiled coil;
KW   Complete proteome; Deafness; Direct protein sequencing;
KW   Disease mutation; Motor protein; Myosin; Neuropathy;
KW   Non-syndromic deafness; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000269|Ref.4}.
FT   CHAIN         2   1995       Myosin-14.
FT                                /FTId=PRO_0000123431.
FT   DOMAIN      105    800       Myosin motor.
FT   DOMAIN      803    832       IQ. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00116}.
FT   NP_BIND     198    205       ATP. {ECO:0000255}.
FT   COILED      862   1947       {ECO:0000255}.
FT   MOD_RES       2      2       N-acetylalanine. {ECO:0000269|Ref.4}.
FT   MOD_RES      60     60       Phosphoserine.
FT                                {ECO:0000269|PubMed:24275569}.
FT   MOD_RES    1662   1662       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P35580}.
FT   MOD_RES    1969   1969       Phosphoserine.
FT                                {ECO:0000269|PubMed:21406692,
FT                                ECO:0000269|PubMed:24275569}.
FT   MOD_RES    1980   1980       Phosphoserine.
FT                                {ECO:0000269|PubMed:24275569}.
FT   MOD_RES    1983   1983       Phosphoserine.
FT                                {ECO:0000269|PubMed:24275569}.
FT   MOD_RES    1989   1989       Phosphoserine.
FT                                {ECO:0000269|PubMed:21406692,
FT                                ECO:0000269|PubMed:24275569}.
FT   VAR_SEQ     231    231       P -> PASVSTVSY (in isoform 2 and isoform
FT                                6). {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:19240025,
FT                                ECO:0000303|Ref.2}.
FT                                /FTId=VSP_040881.
FT   VAR_SEQ     640    640       D -> DEHGGFQQFSFLGSFPPSPPGSAERCSSAISPPG
FT                                (in isoform 2).
FT                                {ECO:0000303|PubMed:19240025,
FT                                ECO:0000303|Ref.2}.
FT                                /FTId=VSP_040882.
FT   VAR_SEQ    1317   1532       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_014628.
FT   VAR_SEQ    1451   1478       MDLEQQRQLVSTLEKKQRKFDQLLAEEK -> LSPDALTDG
FT                                AQPPSSLDPTGPCPRNPAL (in isoform 5).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_014629.
FT   VAR_SEQ    1479   1995       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_014630.
FT   VARIANT     120    120       S -> L (in DFNA4A).
FT                                {ECO:0000269|PubMed:16222661}.
FT                                /FTId=VAR_037302.
FT   VARIANT     266    266       I -> V. {ECO:0000269|PubMed:15015131}.
FT                                /FTId=VAR_022866.
FT   VARIANT     334    334       P -> A (in dbSNP:rs34498817).
FT                                /FTId=VAR_056176.
FT   VARIANT     376    376       G -> C (in DFNA4A).
FT                                {ECO:0000269|PubMed:15015131}.
FT                                /FTId=VAR_022867.
FT   VARIANT     726    726       R -> S (in DFNA4A; dbSNP:rs28940307).
FT                                {ECO:0000269|PubMed:15015131}.
FT                                /FTId=VAR_022868.
FT   VARIANT     933    933       R -> L (in PNMHH).
FT                                {ECO:0000269|PubMed:21480433}.
FT                                /FTId=VAR_066338.
FT   VARIANT     976    976       L -> F (in DFNA4A; dbSNP:rs28940306).
FT                                {ECO:0000269|PubMed:15015131}.
FT                                /FTId=VAR_022869.
FT   VARIANT    1154   1154       A -> V. {ECO:0000269|PubMed:21480433}.
FT                                /FTId=VAR_066339.
FT   VARIANT    1209   1209       A -> E (in dbSNP:rs11669191).
FT                                /FTId=VAR_056177.
FT   VARIANT    1540   1540       V -> I (in dbSNP:rs680446).
FT                                /FTId=VAR_056178.
FT   VARIANT    1559   1559       N -> S. {ECO:0000269|PubMed:15015131}.
FT                                /FTId=VAR_022870.
FT   CONFLICT    411    411       F -> S (in Ref. 5; BG468611).
FT                                {ECO:0000305}.
FT   CONFLICT    444    444       A -> G (in Ref. 5; BG468611).
FT                                {ECO:0000305}.
FT   CONFLICT    446    446       A -> D (in Ref. 5; BG468611).
FT                                {ECO:0000305}.
FT   CONFLICT    458    458       R -> S (in Ref. 5; BG468611).
FT                                {ECO:0000305}.
FT   CONFLICT    466    466       S -> D (in Ref. 5; BG468611).
FT                                {ECO:0000305}.
FT   CONFLICT    473    473       F -> L (in Ref. 5; BG468611).
FT                                {ECO:0000305}.
FT   CONFLICT    997    997       M -> I (in Ref. 5; AAH18933).
FT                                {ECO:0000305}.
FT   HELIX        51     53       {ECO:0000244|PDB:2YCU}.
FT   STRAND       55     60       {ECO:0000244|PDB:2YCU}.
FT   TURN         61     63       {ECO:0000244|PDB:2YCU}.
FT   STRAND       64     73       {ECO:0000244|PDB:2YCU}.
FT   STRAND       75     82       {ECO:0000244|PDB:2YCU}.
FT   TURN         83     85       {ECO:0000244|PDB:2YCU}.
FT   STRAND       88     92       {ECO:0000244|PDB:2YCU}.
FT   HELIX        93     95       {ECO:0000244|PDB:2YCU}.
FT   HELIX       102    104       {ECO:0000244|PDB:2YCU}.
FT   HELIX       110    112       {ECO:0000244|PDB:2YCU}.
FT   HELIX       118    130       {ECO:0000244|PDB:2YCU}.
FT   STRAND      135    138       {ECO:0000244|PDB:2YCU}.
FT   STRAND      141    145       {ECO:0000244|PDB:2YCU}.
FT   HELIX       156    162       {ECO:0000244|PDB:2YCU}.
FT   HELIX       167    169       {ECO:0000244|PDB:2YCU}.
FT   HELIX       174    188       {ECO:0000244|PDB:2YCU}.
FT   STRAND      192    197       {ECO:0000244|PDB:2YCU}.
FT   HELIX       204    218       {ECO:0000244|PDB:2YCU}.
FT   STRAND      222    224       {ECO:0000244|PDB:2YCU}.
FT   STRAND      226    228       {ECO:0000244|PDB:2YCU}.
FT   TURN        237    239       {ECO:0000244|PDB:2YCU}.
FT   HELIX       241    249       {ECO:0000244|PDB:2YCU}.
FT   STRAND      259    270       {ECO:0000244|PDB:2YCU}.
FT   STRAND      276    284       {ECO:0000244|PDB:2YCU}.
FT   HELIX       288    291       {ECO:0000244|PDB:2YCU}.
FT   HELIX       302    310       {ECO:0000244|PDB:2YCU}.
FT   HELIX       313    318       {ECO:0000244|PDB:2YCU}.
FT   HELIX       324    326       {ECO:0000244|PDB:2YCU}.
FT   TURN        338    340       {ECO:0000244|PDB:2YCU}.
FT   HELIX       341    354       {ECO:0000244|PDB:2YCU}.
FT   HELIX       359    374       {ECO:0000244|PDB:2YCU}.
FT   HELIX       375    377       {ECO:0000244|PDB:2YCU}.
FT   STRAND      384    386       {ECO:0000244|PDB:2YCU}.
FT   HELIX       395    403       {ECO:0000244|PDB:2YCU}.
FT   HELIX       408    416       {ECO:0000244|PDB:2YCU}.
FT   STRAND      419    428       {ECO:0000244|PDB:2YCU}.
FT   HELIX       433    463       {ECO:0000244|PDB:2YCU}.
FT   STRAND      471    478       {ECO:0000244|PDB:2YCU}.
FT   STRAND      486    488       {ECO:0000244|PDB:2YCU}.
FT   HELIX       490    510       {ECO:0000244|PDB:2YCU}.
FT   HELIX       512    520       {ECO:0000244|PDB:2YCU}.
FT   HELIX       535    542       {ECO:0000244|PDB:2YCU}.
FT   STRAND      545    547       {ECO:0000244|PDB:2YCU}.
FT   HELIX       550    556       {ECO:0000244|PDB:2YCU}.
FT   STRAND      557    560       {ECO:0000244|PDB:2YCU}.
FT   HELIX       565    576       {ECO:0000244|PDB:2YCU}.
FT   TURN        587    589       {ECO:0000244|PDB:2YCU}.
FT   STRAND      592    598       {ECO:0000244|PDB:2YCU}.
FT   STRAND      601    605       {ECO:0000244|PDB:2YCU}.
FT   HELIX       610    615       {ECO:0000244|PDB:2YCU}.
FT   HELIX       620    627       {ECO:0000244|PDB:2YCU}.
FT   HELIX       632    637       {ECO:0000244|PDB:2YCU}.
FT   HELIX       670    686       {ECO:0000244|PDB:2YCU}.
FT   STRAND      688    696       {ECO:0000244|PDB:2YCU}.
FT   TURN        709    711       {ECO:0000244|PDB:2YCU}.
FT   HELIX       712    719       {ECO:0000244|PDB:2YCU}.
FT   HELIX       721    730       {ECO:0000244|PDB:2YCU}.
FT   STRAND      734    737       {ECO:0000244|PDB:2YCU}.
FT   HELIX       738    745       {ECO:0000244|PDB:2YCU}.
FT   HELIX       746    748       {ECO:0000244|PDB:2YCU}.
FT   TURN        750    752       {ECO:0000244|PDB:2YCU}.
FT   STRAND      771    783       {ECO:0000244|PDB:2YCU}.
FT   HELIX       787    799       {ECO:0000244|PDB:2YCU}.
SQ   SEQUENCE   1995 AA;  227871 MW;  C77AAB26817B773B CRC64;
     MAAVTMSVPG RKAPPRPGPV PEAAQPFLFT PRGPSAGGGP GSGTSPQVEW TARRLVWVPS
     ELHGFEAAAL RDEGEEEAEV ELAESGRRLR LPRDQIQRMN PPKFSKAEDM AELTCLNEAS
     VLHNLRERYY SGLIYTYSGL FCVVINPYKQ LPIYTEAIVE MYRGKKRHEV PPHVYAVTEG
     AYRSMLQDRE DQSILCTGES GAGKTENTKK VIQYLAHVAS SPKGRKEPGV PGELERQLLQ
     ANPILEAFGN AKTVKNDNSS RFGKFIRINF DVAGYIVGAN IETYLLEKSR AIRQAKDECS
     FHIFYQLLGG AGEQLKADLL LEPCSHYRFL TNGPSSSPGQ ERELFQETLE SLRVLGFSHE
     EIISMLRMVS AVLQFGNIAL KRERNTDQAT MPDNTAAQKL CRLLGLGVTD FSRALLTPRI
     KVGRDYVQKA QTKEQADFAL EALAKATYER LFRWLVLRLN RALDRSPRQG ASFLGILDIA
     GFEIFQLNSF EQLCINYTNE KLQQLFNHTM FVLEQEEYQR EGIPWTFLDF GLDLQPCIDL
     IERPANPPGL LALLDEECWF PKATDKSFVE KVAQEQGGHP KFQRPRHLRD QADFSVLHYA
     GKVDYKANEW LMKNMDPLND NVAALLHQST DRLTAEIWKD VEGIVGLEQV SSLGDGPPGG
     RPRRGMFRTV GQLYKESLSR LMATLSNTNP SFVRCIVPNH EKRAGKLEPR LVLDQLRCNG
     VLEGIRICRQ GFPNRILFQE FRQRYEILTP NAIPKGFMDG KQACEKMIQA LELDPNLYRV
     GQSKIFFRAG VLAQLEEERD LKVTDIIVSF QAAARGYLAR RAFQKRQQQQ SALRVMQRNC
     AAYLKLRHWQ WWRLFTKVKP LLQVTRQDEV LQARAQELQK VQELQQQSAR EVGELQGRVA
     QLEEERARLA EQLRAEAELC AEAEETRGRL AARKQELELV VSELEARVGE EEECSRQMQT
     EKKRLQQHIQ ELEAHLEAEE GARQKLQLEK VTTEAKMKKF EEDLLLLEDQ NSKLSKERKL
     LEDRLAEFSS QAAEEEEKVK SLNKLRLKYE ATIADMEDRL RKEEKGRQEL EKLKRRLDGE
     SSELQEQMVE QQQRAEELRA QLGRKEEELQ AALARAEDEG GARAQLLKSL REAQAALAEA
     QEDLESERVA RTKAEKQRRD LGEELEALRG ELEDTLDSTN AQQELRSKRE QEVTELKKTL
     EEETRIHEAA VQELRQRHGQ ALGELAEQLE QARRGKGAWE KTRLALEAEV SELRAELSSL
     QTARQEGEQR RRRLELQLQE VQGRAGDGER ARAEAAEKLQ RAQAELENVS GALNEAESKT
     IRLSKELSST EAQLHDAQEL LQEETRAKLA LGSRVRAMEA EAAGLREQLE EEAAARERAG
     RELQTAQAQL SEWRRRQEEE AGALEAGEEA RRRAAREAEA LTQRLAEKTE TVDRLERGRR
     RLQQELDDAT MDLEQQRQLV STLEKKQRKF DQLLAEEKAA VLRAVEERER AEAEGREREA
     RALSLTRALE EEQEAREELE RQNRALRAEL EALLSSKDDV GKSVHELERA CRVAEQAAND
     LRAQVTELED ELTAAEDAKL RLEVTVQALK TQHERDLQGR DEAGEERRRQ LAKQLRDAEV
     ERDEERKQRT LAVAARKKLE GELEELKAQM ASAGQGKEEA VKQLRKMQAQ MKELWREVEE
     TRTSREEIFS QNRESEKRLK GLEAEVLRLQ EELAASDRAR RQAQQDRDEM ADEVANGNLS
     KAAILEEKRQ LEGRLGQLEE ELEEEQSNSE LLNDRYRKLL LQVESLTTEL SAERSFSAKA
     ESGRQQLERQ IQELRGRLGE EDAGARARHK MTIAALESKL AQAEEQLEQE TRERILSGKL
     VRRAEKRLKE VVLQVEEERR VADQLRDQLE KGNLRVKQLK RQLEEAEEEA SRAQAGRRRL
     QRELEDVTES AESMNREVTT LRNRLRRGPL TFTTRTVRQV FRLEEGVASD EEAEEAQPGS
     GPSPEPEGSP PAHPQ
//
